Department of Epidemiology & Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Beijing 100191, China.
Nutrients. 2022 Oct 11;14(20):4222. doi: 10.3390/nu14204222.
There is limited evidence about the association of healthy lifestyle and all-cause mortality in individuals with metabolic associated fatty liver disease (MAFLD). We aimed to examine this association and compare it with the association in those without MAFLD.
A prospective cohort study was performed and linked mortality data through 2019 in the National Health Nutrition Examination Survey (NHANES 1999-2010). A healthy lifestyle score was constructed from cigarette smoking, alcohol drinking, healthy eating score, and leisure-time physical activity. Risk stratification was conducted in participants with MAFLD by fibrosis biomarkers and liver enzymes. Survey-weight adjusted Cox regression was used to estimate adjusted hazard ratios (HRs) and confidence intervals (CIs) for all-cause mortality associated with healthy lifestyle.
There was a protective association between healthy lifestyle and all-cause mortality in participants with MAFLD (HR per 1-unit increase of healthy lifestyle score 0.77 [95% CI 0.69-0.85]), with no difference from the association in participants without MAFLD (HR 0.77 [0.72-0.82]). In participants with MAFLD, the associations tended to be stronger in those with lower risk of advanced fibrosis (HR per 1-unit increase of healthy lifestyle score 0.64 [0.50-0.79] for low NAFLD fibrosis score [NFS] and 0.84 [0.75-0.93] for high NFS, -value for interaction 0.02), but did not differ by liver enzymes. The results for non-alcoholic fatty liver disease (NAFLD) mirrored those for MAFLD.
Healthy lifestyle showed protective associations with all-cause mortality regardless of MAFLD status, and the associations tended to be stronger in those with lower risk of advanced fibrosis. Timely lifestyle modification matters for individuals with MAFLD.
代谢相关脂肪性肝病(MAFLD)患者的健康生活方式与全因死亡率之间的关联证据有限。本研究旨在检验这种关联,并与非 MAFLD 患者进行比较。
本研究进行了一项前瞻性队列研究,并通过 2019 年国家健康营养调查(NHANES 1999-2010)链接了死亡率数据。健康生活方式评分由吸烟、饮酒、健康饮食评分和休闲时间体力活动构成。通过纤维化生物标志物和肝酶对 MAFLD 患者进行风险分层。采用调查权重调整的 Cox 回归估计与健康生活方式相关的全因死亡率的调整后危险比(HR)和置信区间(CI)。
在 MAFLD 患者中,健康生活方式与全因死亡率之间存在保护关联(健康生活方式评分每增加 1 个单位,HR 为 0.77 [95%CI 0.69-0.85]),与非 MAFLD 患者的关联无差异(HR 0.77 [0.72-0.82])。在 MAFLD 患者中,这种关联在纤维化风险较低的患者中似乎更强(低 NAFLD 纤维化评分(NFS)时,健康生活方式评分每增加 1 个单位的 HR 为 0.64 [0.50-0.79],高 NFS 时为 0.84 [0.75-0.93],交互检验值为 0.02),但与肝酶无关。非酒精性脂肪性肝病(NAFLD)的结果与 MAFLD 相似。
健康的生活方式与全因死亡率呈保护关联,与 MAFLD 状态无关,且在纤维化风险较低的患者中关联更强。及时进行生活方式改变对 MAFLD 患者很重要。